Microarray Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies: An International Prospective Study (INTERCOM)
Version of Record online: 3 OCT 2013
© Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 13, Issue 11, pages 2865–2874, November 2013
How to Cite
Halloran, P. F., Pereira, A. B., Chang, J., Matas, A., Picton, M., De Freitas, D., Bromberg, J., Serón, D., Sellarés, J., Einecke, G. and Reeve, J. (2013), Microarray Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies: An International Prospective Study (INTERCOM). American Journal of Transplantation, 13: 2865–2874. doi: 10.1111/ajt.12465
- Issue online: 28 OCT 2013
- Version of Record online: 3 OCT 2013
- Manuscript Accepted: 1 AUG 2013
- Manuscript Revised: 22 JUL 2013
- Manuscript Received: 17 JUN 2013
Additional Supporting Information may be found in the online version of this article.
|ajt12465-sup-0001-SuppFig-S1.pdf||8K||Figure S1: Accuracy curves. Changes in accuracy, sensitivity and specificity, for predicting a histologic diagnosis of antibody-mediated rejection (ABMR) or mixed, are shown as functions of the ABMR score cutoff. For each cutoff, biopsy samples with scores above the cutoff would be considered as molecularly positive ABMR, whereas those below would be negative. The vertical line at 0.2 shows the cutoff chosen in the original BFC403 paper , and retained for the current INT300 analyses.|
Table S1: Summary diagnosis rules.
Table S2: Demographics.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.